Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-30 21:07:28 - browse：385

Medicare is planning to send $9 billion in lump sum payments to more than 1,600 hospitals that participate in a drug discount program. Adobe

WASHINGTON — Medicare is planning to send $9 billion in lump-sum payments to more than 1,600 hospitals that participate in a drug discount program after the Supreme Court found the program underpaid them for prescription drugs, the agency announced on Friday.

To pay for the restitution, Medicare would slash all hospitals’ payments for other items and services by 0.5% for the next 16 years.

The remedy accounts for four years of underpayments to hospitals that participate in the 340B drug discount program. The Trump administration dramatically reduced Medicare payments for discounted drugs in 2018, but the Supreme Court found they didn’t follow the proper procedure and that the payment scheme was illegal.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： NIH chief: government has fallen behind pharma on clinical trials

Wikipedia

WSS

Medicare Advantage insurers pressure Biden for bigger payments

Healthy food access boosts outcomes in two studies

Adam's Take: Intra

Readout Newsletter: Illumina, CRISPR, Regeneron

What Kate Middleton's cancer revelation might teach the world

Type 2 diabetes prevention programs work at large scale: study

entertainment

Wikipedia

entertainment

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Bright Health sells Medicare Advantage business to Molina

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

The high cost of giving birth even with insurance

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

BioMarin wins approval for gene therapy to treat hemophilia A

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

The cancer drug shortage isn’t new — and neither are the solutions

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

hotspot

'Patient friction coefficient' can gauge a clinical trial's patient burden

Readout Newsletter: Illumina, CRISPR, Regeneron

Steward Health Care expansion into Malta flopped

Carbon Health diabetes program, a test of data

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

FDA reorg will put new emphasis on investigations, sources say

focus

Wikipedia

entertainment

focus